Trial Profile
COFU: A Multi-Center Phase II Clinical Trial to Evaluate the Safety and Efficacy of Weekly Treatment With CoFactor [folitixorin] and 5-Fluorouracil in Patients With Metastatic Colorectal Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2013
Price :
$35
*
At a glance
- Drugs Folitixorin (Primary) ; Fluorouracil
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms COFU
- Sponsors Mast Therapeutics
- 16 Aug 2005 New trial record.